ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.77M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−80.00
Price / share
$493.81
Trade value
$39.50K
% of position
Common Stock
Shares
−1.20K
Price / share
$495.65
Trade value
$595.77K
% of position
Common Stock
Shares
−1.28K
Price / share
$496.73
Trade value
$634.82K
% of position
Common Stock
Shares
−160.00
Price / share
$497.56
Trade value
$79.61K
% of position
Common Stock
Shares
−400.00
Price / share
$498.85
Trade value
$199.54K
% of position
Common Stock
Shares
−519.00
Price / share
$499.73
Trade value
$259.36K
% of position
Common Stock
Shares
−361.00
Price / share
$500.84
Trade value
$180.80K
% of position
Common Stock
Shares
−1.02K
Price / share
$502.87
Trade value
$511.41K
% of position
Common Stock
Shares
−1.14K
Price / share
$503.60
Trade value
$576.12K
% of position
Common Stock
Shares
−964.00
Price / share
$505.03
Trade value
$486.85K
% of position
Common Stock
Shares
−875.00
Price / share
$505.78
Trade value
$442.56K
% of position
Common Stock
Shares
−794.00
Price / share
$506.84
Trade value
$402.43K
% of position
Common Stock
Shares
−506.00
Price / share
$507.68
Trade value
$256.88K
% of position
Common Stock
Shares
−200.00
Price / share
$509.00
Trade value
$101.80K
% of position
Net shares
+0.00
Net value
-$3.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/9/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −80.00 | $493.81 | $39.50K | 0.0% | 333.94K | 333.86K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −1.20K | $495.65 | $595.77K | 0.4% | 333.86K | 332.66K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −1.28K | $496.73 | $634.82K | 0.4% | 332.66K | 331.38K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −160.00 | $497.56 | $79.61K | 0.0% | 331.38K | 331.22K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −400.00 | $498.85 | $199.54K | 0.1% | 331.22K | 330.82K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −519.00 | $499.73 | $259.36K | 0.2% | 330.82K | 330.30K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −361.00 | $500.84 | $180.80K | 0.1% | 330.30K | 329.94K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −1.02K | $502.87 | $511.41K | 0.3% | 329.94K | 328.93K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −1.14K | $503.60 | $576.12K | 0.3% | 328.93K | 327.78K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −964.00 | $505.03 | $486.85K | 0.3% | 327.78K | 326.82K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −875.00 | $505.78 | $442.56K | 0.3% | 326.82K | 325.94K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −794.00 | $506.84 | $402.43K | 0.2% | 325.94K | 325.15K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −506.00 | $507.68 | $256.88K | 0.2% | 325.15K | 324.64K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −200.00 | $509.00 | $101.80K | 0.1% | 324.64K | 324.44K |
| Total | +0.00 | -$3.65M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
470.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 9/9/2026 | M · Option Exercise | −9.50K | 117.76 | — | 470.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 8.90K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |